BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 18550621)

  • 1. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
    PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal immune responses to EBV in early MS.
    Jaquiéry E; Jilek S; Schluep M; Meylan P; Lysandropoulos A; Pantaleo G; Du Pasquier RA
    Eur J Immunol; 2010 Mar; 40(3):878-87. PubMed ID: 20017197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
    Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
    J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
    Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
    Lindsey JW; Hatfield LM; Crawford MP; Patel S
    Mult Scler; 2009 Feb; 15(2):153-8. PubMed ID: 18845656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Fogg MH; Wirth LJ; Posner M; Wang F
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.
    Dungan L; Dunne J; Savio M; Kalaszi M; McElheron M; Lynagh Y; O'Driscoll K; Roche C; Qureshi A; Crowley B; Conlon N; Kearney H
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200217. PubMed ID: 38547427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.